Purchased a FORA.tv video on another website? Login here with the temporary account credentials included in your receipt.
Good medicine is costly, and out of reach for many economic brackets - but how do you measure health against that? Dr. Lowell Schnipper wrestles with these concepts on a daily basis.
Colorado Democratic Representative Diane DeGette explains how in the field of fast research, the FDA provides more roadblocks than shortcuts.
Kirsten Alexsen of Pfizer talks about how innovation needs to turn away from massive budgets if they want to keep the business manageable and affordable to the consumer.
Rena Fox Lays out the current state of affairs of the Hepatitis C epidemic and how it is being treated in patients.
Alan Coukell describes a Scandinavian clinical trial where data was used to help thousands of people for very little cost.
Former Federal Minister of Health in Germany, Daniel Bahr assesses the positive qualities of the US Healcare system.